Telix Pharmaceuticals Target Price Raised 2.4% to A$30.00/Share by Jefferies>TLX.AU

Dow Jones2026/09/14 22:34

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

BioMarin files Form 3 for director Robert M. Plenge, reporting no beneficial ownership

Reuters•2026/09/14 22:49

Bioceres Crop Solutions 4Q Rev $55.9M >BIOX

Dow Jones•2026/09/14 22:49

Red Robin files Form 3 beneficial ownership statement for CMO Scott Hudler

Reuters•2026/09/14 22:42

Senator Lummis Releases CLARITY Act Final Draft Ahead of Key Vote

Coinpedia•2026/09/14 22:30